# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001140361-22-040706
Filing Date
2022-11-09
Accepted
2022-11-09 16:31:04
Documents
28
Period of Report
2022-11-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | brhc10043928_8k.htm iXBRL | 8-K | 29814
2 | EXHIBIT 99.1 | brhc10043928_ex99-1.htm | EX-99.1 | 29513
6 |  | brhc10043928_99-1slide1.jpg | GRAPHIC | 114624
7 |  | brhc10043928_99-1slide2.jpg | GRAPHIC | 263194
8 |  | brhc10043928_99-1slide3.jpg | GRAPHIC | 149446
9 |  | brhc10043928_99-1slide4.jpg | GRAPHIC | 94345
10 |  | brhc10043928_99-1slide5.jpg | GRAPHIC | 117209
11 |  | brhc10043928_99-1slide6.jpg | GRAPHIC | 136214
12 |  | brhc10043928_99-1slide7.jpg | GRAPHIC | 90540
13 |  | brhc10043928_99-1slide8.jpg | GRAPHIC | 102795
14 |  | brhc10043928_99-1slide9.jpg | GRAPHIC | 100638
15 |  | brhc10043928_99-1slide10.jpg | GRAPHIC | 166496
16 |  | brhc10043928_99-1slide11.jpg | GRAPHIC | 140465
17 |  | brhc10043928_99-1slide12.jpg | GRAPHIC | 107188
18 |  | brhc10043928_99-1slide13.jpg | GRAPHIC | 119919
19 |  | brhc10043928_99-1slide14.jpg | GRAPHIC | 110251
20 |  | brhc10043928_99-1slide15.jpg | GRAPHIC | 90084
| Complete submission text file | 0001140361-22-040706.txt |  | 2827341

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | erna-20221109.xsd | EX-101.SCH | 3866
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | erna-20221109_lab.xml | EX-101.LAB | 22547
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | erna-20221109_pre.xml | EX-101.PRE | 16045
22 | EXTRACTED XBRL INSTANCE DOCUMENT | brhc10043928_8k_htm.xml | XML | 4238

Mailing Address 10355 SCIENCE CENTER DRIVE SUITE 150 SAN DIEGO CA 92121
Business Address 10355 SCIENCE CENTER DRIVE SUITE 150 SAN DIEGO CA 92121 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11460 | Film No.: 221373165
SIC: 2834 Pharmaceutical Preparations